Piracetam(Nootropyl) 学術文献集
文献No. | 【標題/著者/誌名/内容】 | |
67-1 | A GABA-related hypothesis on the mechanism of action of the antimotion sickness drugs | |
(抗動揺病薬の作用機序におけるGABA関連仮説) | ||
C. Giurgea, F. Moyer soons and A. C. Evraerd | ||
Arch. Int. Pharmacodyn. Ther. 166, 238-251 (1967) | ||
GABAから誘導された薬剤Piracetamによる | ||
70-1 | Differential pharmacological reactivity of three types of Cortical evoked potentials | |
(3タイプの皮質誘発電位の特異的な薬理学的反応性) | ||
C. Giurgea and F. Moyer soons | ||
Arch. Int. Pharmacodyn. 188, 401-404 (1970) | ||
71-1 | Pharmacological protection against Hypoxia induced Amnesia in rats | |
(ラットでの低酸素誘導性貧血に対する薬理学的予防) | ||
C. Giurgea, and et al. | ||
Psychopharmacologia(Berl.) 20, 160-168 (1971) | ||
72-1 | The clinical use of Piracetam, a new nootropic drug | |
(新しい向知性薬ピラセタムの臨床用途) | ||
A. J. Stegink | ||
Arzneim.-Forsch. (Drud Res.) 22(6), 975-977 (1972) | ||
72-2 | On the pharmacology of cortical potentials | |
(皮質電位の薬理学について) | ||
C. E. Giurgea and F. E. Moyersoons | ||
Arch. Int. Pharmacodyn. 199, 67-78, (1972) | ||
76-1 | Piracetam-induced improvement of mental performance | |
(ピラセタム誘導による精神能力の改善) | ||
P. Mindus et al. | ||
Acta Psychiat. Scand. 54, 150-160 (1976) | ||
76-2 | Piracetam-induced facilitation of interhemispheric transfer of visual information in rats | |
(ピラセタム誘導によるラットでの視覚情報の大脳半球間転移の促進) | ||
O. Buresova and J. Bures | ||
Psychopharmacologia(Berl.) 46, 93-102, (1976) | ||
76-3 | Effect of the acquisition-enhancing drug Piracetam on rat cerebral energy metabolism. Comparison with Naftidrofuryl and Metaamphetamine | |
(ラットの脳エネルギー代謝における捕捉増強薬ピラセタムの効果。ナフチドロフリル、メタアンフェタミンとの比較) | ||
V. J. Nickolson and O. L. Wolthuis | ||
Biochem. Pharmacol. 25, 2241-44, (1976) | ||
78-1 | Piracetam in the tratment of Post-concussional syndrome A double-blind study |
|
(脳震盪後症候群治療におけるピラセタム。二重盲験試験。 | ||
H. Hakkarainen and L. Hakamies | ||
Euro. Neurol. 17, 50-55 (1978) | ||
79-1 | Some effects of Piracetam (UCB6215 Nootropyl) on chronic Schizophrenia | |
(慢性統合失調症に対するピラセタm(UCB6215 Nootropyl)の効果 | ||
S. J. Dimond et al. | ||
Psychopharmacol. 64, 341-348, (1979) | ||
80-1 | The efficacy of Piracetam in Vertigo -- A double-blind study in patients with central origin | |
(めまいにおけるピラセタムの効能−−中枢起源患者での二重盲験試験) | ||
W. J. Oosterveld | ||
Arzneim.-Forsch./Drug res. 30(U) 1947-1949 (1980) | ||
81-1 | A double-blind, placebo-controlled study of Piracetam in elderly psychiatric patients | |
(高齢の精神病患者でのピラセタムの二重盲験、プラセボ対照試験) | ||
G. Chouinard et al. | ||
Psychopharmacol. Bull. 17, 129 (1981) | ||
81-2 | Profound effects of combining Choline and Piracetam on memory enhancement and cholinergic function in aged rats | |
(高齢マウスでのコリンとピラセタム併用による記憶力増強およびコリン作動性機能における著しい効果) | ||
R. T. Bartus et al. | ||
Neurobiol. Aging 2, 105-111 (1981) | ||
82-1 | Combination Choline/Piracetam treatment of Senile Dementia | |
(老年性認知症治療におけるコリンとピラセタムの併用) | ||
S. T. Ferris et al. | ||
Psychopharmacol. Bull. 18, 94-98 (1982) | ||
83-1 | Piracetam in erderly psychiatric patitients with mild diffuse cerebral impairment | |
(軽度の広範性脳障害をともなう高齢の精神病患者におけるピラセタム) | ||
G. Chouinard et al. | ||
Psychopharmacol. 81, 100-106 (1983) | ||
83-2 | The efficacy of the Cerebral metabolic enhancers in the treatment of Senile Demencia | |
(老年性認知症治療における脳代謝増強薬の効果) | ||
R. J. Branconnier | ||
Psychopharmacol. Bull. 19, 212-219 (1983) | ||
84-1 | Pharmacological treatment of Arzheimer's-type Dementia: New approaches | |
(アルツハイマー型認知症の薬理学的治療−新たな研究 | ||
R. C. Smith & B. Reisberg | ||
Psychopharmacol. Bull. 20, 542-545 (1984) | ||
85-1 | The effect of Piracetam in children with Dyslexia | |
(失読症の子供に対するピラセタムの効果) | ||
M. D. Ianni et al. | ||
J. Clin. Psychopharmacol. 5, 272-278 (1985) | ||
85-2 | Piracetam in alcoholic psychoses: A double-blind, crossover, placebo controlled study | |
(アルコール性精神病におけるピラセタム:二重盲験、クロスオーバー、プラセボ対照試験) | ||
V. Skondia and J. Kabes | ||
J. Int. Med. Res. 13, 185-187 (1985) | ||
86-1 | Evaluation of the efficacy of Piracetam in treating information processing, reading and writing disorders in Dyslexic children | |
(失読症の子供の情報処理および読み書き能力治療におけるピラセタムの効果についての評価) | ||
P. Tallal et al. | ||
Int. J. Clin. Psychophysiol. 4, 41-52 (1986) | ||
86-2 | Effects of Pracetam on developmental Dyslexia | |
(発達性失読症に対するピラセタムの効果) | ||
C. R. Wilsher | ||
Int. J. Clin. Psychophysiol. 4, 29-39 (1986) | ||
86-3 | Synergistic effects of Oxiracetam and Piracetam in combination with antiepileptic drug | |
(オキシラセタムとピラセタムの抗てんかん薬との併用による相乗効果) | ||
C. Mondadori and M. Schmutz | ||
Acta Neurol. Scand. 74(Suppl 109), 113-116 (1986) | ||
86-4 | Antimyoclonic action of Piracetam | |
(ピラセタムの抗ミオクローヌス作用) | ||
J. A. Obeso et al. | ||
Clin. Neuropharmacol. 9(1), 58-64 (1986) | ||
86-5 | Effects of Oxiracetam on lerning and memory in animals: Comparison with Piracetam | |
(動物の学習と記憶におけるオキシラセタムの効果:ピラセタムとの比較) | ||
C. Mondadori et al. | ||
Clin. Neuropharmacol. 9(Suppl3), S27-S38 (1986) | ||
87-1 | Piracetan and Dyslexia: Effects on reading test | |
(ピラセタムと失読症:読解テストにおける効果) | ||
C. R. Wilsher et al. | ||
J. Clin. Psychopharmacol. 7(4), 230-237 (1987) | ||
87-2 | Reversal of scopolamine-induced amnesia and alteration in energy metabolism by the nootropic Piracetam: implications regarding identification of brain structure involved in consolidation of memory traces | |
(スコポラミン誘導性記憶喪失障害の逆行と抗知性薬ピラセタムによるエネルギー代謝の改善:記憶痕跡硬化を伴う脳構造の検証に関する示唆) | ||
M. F. Piercey et al. | ||
Brain Res. 424, 1-9 (1987) | ||
88-1 | Randomized placebo-controlled double-blind cross-over study on antihypoxidotic effects of Piracetam using psychophysiological measures in healthy voluntieer | |
(健康な志願者に心理学生理学的尺度を使用したピラセタムの抗低酸素効果における無作為抽出プラセボ対照二重盲験クロスオーバー試験) | ||
K. Schaffler and W. Klausnittzer | ||
Arzneim. Forsch/Drug Res. 38, 288-291 (1988) | ||
88-2 | Piracetam elevates muscarinic cholinergic recepter density in the frontal cortex of aged but not of young mice | |
(ピラセタムは若くない高齢マウスの前頭葉のムスカリン性コリン受容体密度を上昇させる) | ||
H. Pilch and W. E. Mueller | ||
Psychopharmacol. 94, 74-78 (1988) | ||
88-3 | Action of Nootropic drugs on transcallosal responses in rats | |
(ラットでの脳梁転移応答における抗知性薬の作用) | ||
S. Okuyama and H. Aihara | ||
Neuropharmacol. 27, 67-72 (1988) | ||
89-1 | Nootropic drugs and brain cholinergic mechanisms | |
(抗知性薬と脳のコリン作動機序) | ||
G. Pepeu and G. Spignoli | ||
Prog. Neuro-Psychopharmacol. & Biol. Psychiat. 13, S77-s88 (1989) | ||
91-1 | Age-related deficits on central muscarinic cholinergic receptor function in mouse: Partial restration by chronic Piracetam treatment | |
(マウスの中枢ムスカリン性受容体機能での年齢誘導欠損) | ||
L. Stoll at al. | ||
Neurobiol. Aging 13, 39-44 (1991) | ||
92-1 | Clinical use of Piracetam in Epileptic patients | |
(てんかん患者に対するピラセタムの臨床用途) | ||
H. R. Chaurhry et al. | ||
Curr. Ther. Res. 52(3), 355-360 (1992) | ||
93-1 | On the efficacy of Piracetam in geriatric patients with acute cerebral ischemia: A clinically controlled double-blind study | |
(急性脳虚血をともなう高齢患者でのピラセタムの効能について:臨床的にコントロールされた二重盲験試験) | ||
D. Platt et al. | ||
Arch. Geront. Geriatr. 16, 149-164 (1993) | ||
93-2 | Lomg-term and high-dose Piracetam treatment of Alzheimer's disease | |
(アルツハイマー病の長期高投与ピラセタム治療) | ||
B. Croisile et al. | ||
Neurology 43, 301-305 (1993) | ||
93-3 | Efficacy of cerebroprotective substances in the management of functional disorders induced by the cytotoxic brain oedema-producing substances hexachlorophene | |
(細胞毒性脳浮腫生成物質ヘキサクロロフェンによって誘導される機能障害治療における脳保護物質の効能) | ||
K. Andereas | ||
Naunyn-Schiedeberg's Arch Pharmacol. 347, 79-83 (1993) | ||
93-4 | Treatment of the Raynud's phenomenon with Piracetam | |
(ピラセタムによるレイノー現象の治療) | ||
M. Moriau et al. | ||
Arzneim-Forsch./Drug Res. 43(5), 526-535 (1993) | ||
94-1 | Piracetam and other structurally related nootropics | |
(ピラセタムと他の構造的に誘導された抗知性薬) | ||
A. H. Gouliaev and A. Senning | ||
Brain Res. Rev. 19, 180-222 (1994) | ||
94-2 | Interaction between psychological and pharmacological treatment in cognitive impairment | |
(認識機能障害における心理学的および薬理学的治療の間の相互作用) | ||
W. Deberdt | ||
Life Science 55, 2057-2066 (1994) | ||
08-1 | Towards responsible use of cognitive-enhancing drugs by the healthy | |
(健常者による認識促進薬の責任ある利用について) | ||
Nature 456, Dec 11 2008, 702-705 (2008) |